Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. R&D Systems™ CGP 78608 hydrochloride

R&D Systems™ CGP 78608 hydrochloride
GREENER_CHOICESDP

Catalog No. 149350 Shop All Novus Products
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
14-935-0 50 mg
14-931-0 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 14-935-0 Supplier R&D Systems™ Supplier No. 1493/50

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

Description

A Tocris product, part of R&D Systems. Potent, selective glycine-site NMDA antagonist

Potent and selective NMDA antagonist that acts through the glycine site (IC50 = 5 nM). Displays > 500-fold selectivity over kainate and AMPA receptors (IC50 values are 2.7 and 3 μM respectively). Also potentiates GluN1/GluN3A-mediated glycine currents (EC50 = 26.3 nM). Anticonvulsant in vivo following systemic administration.

Chemical Identifiers

CAS 1135278-54-4
Molecular Formula C11H14BrClN3O5P

Specifications

Quantity 50 mg
Product Line Tocris
Formula Weight 414.58
Purity >98%
Molecular Weight (g/mol) 414.577
Chemical Name or Material CGP 78608 hydrochloride

Safety and Handling

Recommended Storage Store at Room Temperature
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.